UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Increased secretory leukocyte protease inhibitor (SLPI) production by highly metastatic mouse breast cancer cells

PloS one, 2014-08, Vol.9 (8), p.e104223

2014

Volltextzugriff (PDF)

Bortezomib sensitizes human renal cell carcinomas to TRAIL apoptosis through increased activation of caspase-8 in the death-inducing signaling complex

Molecular cancer research, 2010-05, Vol.8 (5), p.729-738

2010

Volltextzugriff (PDF)

The proteasome inhibitor PS-341 sensitizes neoplastic cells to TRAIL-mediated apoptosis by reducing levels of c-FLIP

Blood, 2003-07, Vol.102 (1), p.303-310

2003

Volltextzugriff (PDF)

cell-based high-throughput screen to identify synergistic TRAIL sensitizers

Cancer Immunology, Immunotherapy, 2009-08, Vol.58 (8), p.1229-1244

2009

Volltextzugriff (PDF)

Tumor-Specific CTL Kill Murine Renal Cancer Cells Using Both Perforin and Fas Ligand-Mediated Lysis In Vitro, But Cause Tumor Regression In Vivo in the Absence of Perforin

The Journal of immunology (1950), 2002-04, Vol.168 (7), p.3484-3492

2002

Volltextzugriff (PDF)

Withanolides from Aeroponically Grown Physalis peruviana and Their Selective Cytotoxicity to Prostate Cancer and Renal Carcinoma Cells

Journal of natural products (Washington, D.C.), 2017-07, Vol.80 (7), p.1981-1991

2017

Volltextzugriff (PDF)

Cytotoxic and other withanolides from aeroponically grown Physalis philadelphica

Phytochemistry (Oxford), 2018-08, Vol.152, p.174-181

2018

Volltextzugriff (PDF)

Ring A/B-Modified 17β-Hydroxywithanolide Analogues as Antiproliferative Agents for Prostate Cancer and Potentiators of Immunotherapy for Renal Carcinoma and Melanoma

Journal of natural products (Washington, D.C.), 2021-12, Vol.84 (12), p.3029-3038

2021

Volltextzugriff (PDF)

Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET Proteins

Cancer research (Chicago, Ill.), 2021-06, Vol.81 (12), p.3374-3386

2021

Volltextzugriff (PDF)

17β-Hydroxywithanolides as Sensitizers of Renal Carcinoma Cells to Tumor Necrosis Factor‑α Related Apoptosis Inducing Ligand (TRAIL) Mediated Apoptosis: Structure–Activity Relationships

Journal of medicinal chemistry, 2017-04, Vol.60 (7), p.3039-3051

2017

Volltextzugriff (PDF)

The Proteasome Inhibitor Bortezomib (Velcade) Sensitizes Some Human Tumor Cells to Apo2L/TRAIL-Mediated Apoptosis

Annals of the New York Academy of Sciences, 2005-11, Vol.1059 (1), p.160-167

2005

Volltextzugriff (PDF)

Bortezomib Improves Adoptive T-cell Therapy by Sensitizing Cancer Cells to FasL Cytotoxicity

Cancer research (Chicago, Ill.), 2015-12, Vol.75 (24), p.5260-5272

2015

Volltextzugriff (PDF)

The Restricted Expression of Granzyme M in Human Lymphocytes

The Journal of immunology (1950), 2001-01, Vol.166 (2), p.765-771

2001

Volltextzugriff (PDF)

Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow

The Journal of immunology (1950), 2009-04, Vol.182 (7), p.4328-4338

2009

Volltextzugriff (PDF)

Antigen Presented by Tumors In vivo Determines the Nature of CD8+ T-Cell Cytotoxicity

Cancer research (Chicago, Ill.), 2009-08, Vol.69 (16), p.6615-6623

2009

Volltextzugriff (PDF)

Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis is an important endogenous mechanism for resistance to liver metastases in murine renal cancer

Cancer research (Chicago, Ill.), 2003, Vol.63 (1), p.207-213

2003

Volltextzugriff (PDF)

T cell lysis of murine renal cancer: multiple signaling pathways for cell death via Fas

Journal of leukocyte biology, 2000-07, Vol.68 (1), p.81-86

2000

Volltextzugriff (PDF)

Effects of cucurbitacins on cell morphology are associated with sensitization of renal carcinoma cells to TRAIL-induced apoptosis

Apoptosis (London), 2012, Vol.17 (1), p.79-89

2012

Volltextzugriff (PDF)

Reduction of the antiapoptotic protein cFLIP enhances the susceptibility of human renal cancer cells to TRAIL apoptosis

Cancer Immunology, Immunotherapy, 2005-05, Vol.54 (5), p.499-505

2005

Volltextzugriff (PDF)

NK Cells Use NKG2D to Recognize a Mouse Renal Cancer (Renca), yet Require Intercellular Adhesion Molecule-1 Expression on the Tumor Cells for Optimal Perforin-Dependent Effector Function

Journal of Immunology, 2006-08, Vol.177 (4), p.2575-2583

2006

Volltextzugriff (PDF)

Molecular Mechanisms of Immune-Mediated Lysis of Murine Renal Cancer: Differential Contributions of Perforin-Dependent Versus Fas-Mediated Pathways in Lysis by NK and T Cells

The Journal of immunology (1950), 1998-10, Vol.161 (8), p.3957-3965

1998

Volltextzugriff (PDF)

Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras

Cancer research (Chicago, Ill.), 1998-08, Vol.58 (15), p.3391-3400

1998

Volltextzugriff (PDF)

Abstract 2159: A specific 17-beta-hydroxywithanolide (LG-02) sensitizes cancer cells to apoptosis in response to TRAIL and TLR3 ligands

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2159-2159

2017

Volltextzugriff (PDF)

Abstract 2313: Promoting caspase-8-dependent apoptosis signaling using 17-beta-hydroxywithanolides

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2313-2313

2017

Volltextzugriff (PDF)

Abstract 2671: 17beta-hydroxywithanolides inhibit the proliferation of castration-resistant prostate cancer cells by reducing levels of cFLIP

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2671-2671

2018

Volltextzugriff (PDF)

1 – 25 von 414

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(386)
Mit Volltextzugriff
(353)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(412)
Spanisch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(280)
Life Sciences & Biomedicine
(230)
Humans
(178)
Male
(105)
Female
(96)
Biological And Medical Sciences
(86)
Animals
(67)
Medical Sciences
(66)
Middle Aged
(61)
Adult
(51)
Aged
(49)
Physical Sciences
(39)
Immunology
(27)
Mice
(27)
Risk Factors
(27)
Oncology
(26)
Fundamental And Applied Biological Sciences. Psychology
(23)
United States
(23)
Science & Technology - Other Topics
(22)
Multidisciplinary Sciences
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Increased secretory leukocyte protease inhibitor (SLPI) production by highly metastatic mouse breast cancer cells

Bortezomib sensitizes human renal cell carcinomas to TRAIL apoptosis through increased activation of caspase-8 in the death-inducing signaling complex

The proteasome inhibitor PS-341 sensitizes neoplastic cells to TRAIL-mediated apoptosis by reducing levels of c-FLIP

cell-based high-throughput screen to identify synergistic TRAIL sensitizers

Tumor-Specific CTL Kill Murine Renal Cancer Cells Using Both Perforin and Fas Ligand-Mediated Lysis In Vitro, But Cause Tumor Regression In Vivo in the Absence of Perforin

Withanolides from Aeroponically Grown Physalis peruviana and Their Selective Cytotoxicity to Prostate Cancer and Renal Carcinoma Cells

Cytotoxic and other withanolides from aeroponically grown Physalis philadelphica

Ring A/B-Modified 17β-Hydroxywithanolide Analogues as Antiproliferative Agents for Prostate Cancer and Potentiators of Immunotherapy for Renal Carcinoma and Melanoma

Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET Proteins

17β-Hydroxywithanolides as Sensitizers of Renal Carcinoma Cells to Tumor Necrosis Factor‑α Related Apoptosis Inducing Ligand (TRAIL) Mediated Apoptosis: Structure–Activity Relationships

The Proteasome Inhibitor Bortezomib (Velcade) Sensitizes Some Human Tumor Cells to Apo2L/TRAIL-Mediated Apoptosis

Bortezomib Improves Adoptive T-cell Therapy by Sensitizing Cancer Cells to FasL Cytotoxicity

The Restricted Expression of Granzyme M in Human Lymphocytes

Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow

Antigen Presented by Tumors In vivo Determines the Nature of CD8+ T-Cell Cytotoxicity

Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis is an important endogenous mechanism for resistance to liver metastases in murine renal cancer

T cell lysis of murine renal cancer: multiple signaling pathways for cell death via Fas

Effects of cucurbitacins on cell morphology are associated with sensitization of renal carcinoma cells to TRAIL-induced apoptosis

Reduction of the antiapoptotic protein cFLIP enhances the susceptibility of human renal cancer cells to TRAIL apoptosis

NK Cells Use NKG2D to Recognize a Mouse Renal Cancer (Renca), yet Require Intercellular Adhesion Molecule-1 Expression on the Tumor Cells for Optimal Perforin-Dependent Effector Function

Molecular Mechanisms of Immune-Mediated Lysis of Murine Renal Cancer: Differential Contributions of Perforin-Dependent Versus Fas-Mediated Pathways in Lysis by NK and T Cells

Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras

Abstract 2159: A specific 17-beta-hydroxywithanolide (LG-02) sensitizes cancer cells to apoptosis in response to TRAIL and TLR3 ligands

Abstract 2313: Promoting caspase-8-dependent apoptosis signaling using 17-beta-hydroxywithanolides

Abstract 2671: 17beta-hydroxywithanolides inhibit the proliferation of castration-resistant prostate cancer cells by reducing levels of cFLIP

Suchergebnisse filtern